Abstract
We utilized a CRISPR interference (CRISPRi) assay to control the gene expressions of two predicted essential peptidoglycan biosynthesis genes, pbpB and cwIM, in Mycobacterium abscessus and to evaluate their contribution to b-lactam susceptibility. Our results showed that CRISPR inhibition of each gene led to a significant 3-log10 reduction in CFU in the presence of imipenem but not for cefoxitin. These results demonstrate that CRISPRi provides an experimental approach to study drug/ target interactions in M. abscessus.
Original language | English (US) |
---|---|
Journal | Antimicrobial agents and chemotherapy |
Volume | 66 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2022 |
Keywords
- CRISPRi
- Mycobacterium abscessus
- b-lactam
- peptidoglycan biosynthesis
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Pharmacology